Elotuzumab API Manufacturers
compare suppliers & get competitive offers
Filters
Reset
Selected filters:
Type
Production region
Qualifications
To view suppliers for this material, you need to be logged in first.
This is because of international laws regarding narcotic materials. Furthermore, the contents of this page are only accessible if you are professionaly active in the pharmaceutical industry. In case you are, it is possible to register on our platform, and after your account is approved by our team you will be able to view suppliers and send your request.
Looking for Elotuzumab API 915296-00-3?
- Description:
- Here you will find a list of producers, manufacturers and traders of Elotuzumab. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Elotuzumab
- Synonyms:
- Cas Number:
- 915296-00-3
- DrugBank number:
- DB06317
- Unique Ingredient Identifier:
- 1351PE5UGS
About Elotuzumab
What makes Elotuzumab unique? Elotuzumab is a humanized IgG1 (Immunoglobulin G) monoclonal antibody indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received one to three prior therapies. Elotuzumab targets SLAMF7, also known as Signaling Lymphocytic Activation Molecule Family member a cell surface glycoprotein. Elotuzumab consists of the complementary determining regions (CDR) of the mouse antibody, MuLuc63, grafted onto human IgG1 heavy and kappa light chain frameworks. Elotuzumab is produced in NS0 cells by recombinant DNA technology.
Elotuzumab has a theoretical mass of 148. kDa for the intact antibody. Elotuzumab was approved on November 30, 2015 by the USA Food and Drug Administration. Elotuzumab is marketed under the brand Empliciti™ by Bristol-Myers Squibb.
Not sure if this is the exact product you're looking for? Contact the supplier by using the send inquiry button.
